NCT06904170 Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma Status RECRUITING Phase PHASE2/PHASE3
NCT06899633 Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06899061 Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06897930 A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE Status RECRUITING Phase PHASE1/PHASE2
NCT06897748 A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils Status COMPLETED Phase PHASE2
NCT06890598 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06890273 NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife) Status RECRUITING Phase N/A
NCT06884267 Hyperkalemia Quality Improvement Program (HK-QIP) Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT06883305 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) Status RECRUITING Phase PHASE3
NCT06880523 STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06880354 A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Status RECRUITING Phase PHASE1
NCT06879041 A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT06878261 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007) Status RECRUITING Phase PHASE3
NCT06868277 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06862791 A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone Status COMPLETED Phase PHASE2
NCT06862206 This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab Status RECRUITING Phase N/A
NCT06858735 HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT06857695 A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004 Status COMPLETED Phase PHASE1
NCT06855225 A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma Status NOT_YET_RECRUITING Phase PHASE2